RHB-104 Crohn’s Disease

Start Date: April 12, 2016
Trial Phase: III
Trial Status: open
Therapy Type: Drug


Trial Description:
Patients with Severe Crohn's who have not responded to previous treatments. Patients who have active disease - Oral Therapy

Candidate Profile:
Group Study

Goal of Treatment:
To provide treatment for patients who have not responded previously


Sponsor Name:
To Be Disclosed

Sponsor Information:
While all of our trial sponsors are reputable scientific organizations, the sponsor for this, and many other studies prefers not be identified publicly before the trial is underway. Should you be contacted about participating in this trial, we will share with you the name and background of its sponsor.